302. Shah VH, Rotterdam H, Kotler DP, Fasano A, Green PH. All that scallops is not celiac disease. Gastrointest Endosc 2000; 51: 717–20
303. Katz KD, Rashtak S, Lahr BD, et al. Screening for celiac disease in a North American Population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol 2011; 106: 1333–9
304. Pastore L, Carroccio A, Compilato D, et al. Oral manifestations of celiac disease. J Clin Gastroenterol. 2008;42:224–232
305. Bodvarsson S, Jonsdottir I, Freysdottir J, Leonard JN, Fry L, Valdimarsson T. Dermatitis herpetiformis: an autoimmune disease due to cross-reaction between dietary glutenin and dermal elastin. Scand J Immunol 1993; 38: 546–50
306. Hadjivassiliou M, Sanders DS, Grünewald RA, et al. Gluten sensitivity: from gut to brain. Lancet Neurol 2010; 9: 318–30
307. Leonard JN, Tucker WF, Fry JS, et al. Increased incidence of malignancy in dermatitis herpetiformis. BMJ 1983; 286 (Clin Res Ed): 16–18
308. Rostom A, Dubé C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005; 128 (4 Suppl 1): 38–46
309. Rumessen JJ. Serologisk screening for cøliaki. Ugeskr Læger 2004; 166: 2142–4
310. Sategna-Guidetti C, Pulitano R, Grosso S, Ferfoglia G. Serum IgA antiendomysium antibody titers as a marker of intestinal involvement and diet compliance in adult celiac sprue. J Clin Gastroenterol 1993; 17: 123–27
311. Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003;348:2517–2524
312. Fasano A. European and North American populations should be screened for coeliac disease. Gut 2003; 152: 168–9
313. Valdimarsson T, Toss G, Ross I, Lofman O, Strom M. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: 457–61
314. Scotta MS, Salvatore S, Salvatoni A, et al. Bone mineralization and body composition in young patients with celiac disease. Am J Gastroenterol 1997; 92: 1331–34
315. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology 1992; 102: 330–54
316. Garsed K, Scott BB. Can oats be taken in a gluten-free diet? A systematic review. Scand J Gastroenterol 2007; 42: 171–8
317. Løvik A, Lundin KEA. «Kostbehandling av cøliaki og dermatitis herpetiformis». Tidsskr Nor Lægeforen 2003; 123: 3237–40
318. Johnson D. Novel Drug for Celiac Disease Reduces GI and Non-GI Symptoms. Digestive Disease Week (DDW) 2014. Abstract 929f. Presented May 7, 2014. http://www.medscape.com/viewarticle/824778?sr…
319. Castillo NE, Theethira TG, Leffler DA. The present and the future in the diagnosis and management of celiac disease. Gastroenterol. Rep. (2015) 3 (1): 3–11
320. Ilus T, Kaukinen K, Virta LJ, et al. Incidence of malignancies in diagnosed celiac patients. Am J Gastroenterol 2014; 109(9): 1471–77
321. Fickling WE, McFarlane XA, Bhalla AK, Robertson DAF. The clinical impact of metabolic bone disease in coeliac disease. Postgrad Med 2001; 77: 33–6
322. Farthing MJ, Edwards CR, Rees LH, Dawson AM. Male gonadal function in coeliac disease: 1 sexual dysfunction, infertility, and semen quality. Gut 1982; 23: 608–14
323. Thawani SP, Brannagan TH, Lebwohl B, et al. Risk of neuropathy among 28 232 patients with biopsy-verified Celiac disease. JAMA Neurology 2015. doi:10.1001/jamaneurol. 2015.0475
324. Evans KE, Leeds JS, Morley S et.al. Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation? Dig Dis Sci 2010; 55: 2999–3004
325. Collin P, Reunala T, Pukkala E, Laippala P, Keyrilainen O, Pasternack A. Coeliac disease-associated disorders and survival. Gut 1994; 35: 1215–18
326. Corrao G, Corazza GR, Bagnardi V, et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001; 358: 356–61
327. Peters U, Askling J, Gridley G, Ekbom A, Linet M. Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med 2003; 163: 1566–72
328. Sultan AA, Tata LJ, Fleming KM, et al. Pregnancy complications and adverse birth outcomes among women with celiac disease. Am J Gastroenterol. 2014;109:1653–1661
329. Fagrådet i Norsk Cøliakiforening. Retningslinjer – cøliaki. 2004
330. Vanuytsel, T; et al. The role of Haptoglobin and its related protein, Zonulin, in inflammatory bowel disease. Tissue Barriers 2013. 1 (5): e27321
331. Fasano, A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol Rev. 2011 91 (1): 151–75
332. Lammers, Karen M.; Lu, Ruliang; Brownley, Julie; Lu, Bao; Gerard, Craig; Thomas, Karen; Rallabhandi, Prasad; Shea-Donohue, Terez; Tamiz, Amir. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 2008. 135 (1): 194–204.e3
333. Visser, Jeroen; Rozing, Jan; Sapone, Anna; Lammers, Karen; Fasano, Alessio. «Tight Junctions, Intestinal Permeability, and Autoimmunity Celiac Disease and Type 1 Diabetes Paradigms». Annals of the New York Academy of Sciences 2009. 1165: 195–205
334. Fasano, Alessio. «Zonulin and Its Regulation of Intestinal Barrier Function: The Biological Door to Inflammation, Autoimmunity, and Cancer». Physiological Reviews 2011. 91 (1): 151–175
335. Lemmer, HJ; Hamman, JH. Paracellular drug absorption enhancement through tight junction modulation. Expert Opin Drug Deliv 2013. 10 (1): 103–14
336. NRP. A proteinin the gut may explain why some can’t stomach gluten http://www.npr.org/sections/thesalt/2015/12/09/459061317/a-protein-in-the-gut-may-explain-why-some-cant-stomach-gluten?utm_medium=RSS&utm_campaign=food
337. Umberto Volta, Maria Teresa Bardella, Antonino Calabrò, Riccardo Troncone, Gino Roberto Corazza. An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med. 2014; 12: 85
338. Luca Elli, Federica Branchi, Carolina Tomba, Danilo Villalta, Lorenzo Norsa, Francesca Ferretti, Leda Roncoroni, Maria Teresa Bardella. Diagnosis of gluten related disorders: Celiac disease, wheat allergy and non-celiac gluten sensitivity. World J Gastroenterol. 2015 June 21; 21(23): 7110–7119
339. Umberto Volta, Giacomo Caio, Francesco Tovoli, Roberto De Giorgio. Non-celiac gluten sensitivity: questions still to be answered despite increasing awareness. Cell Mol Immunol. 2013 September; 10(5): 383–392
340. Francesco Sofi, Anne Whittaker, Anna Maria Gori, Francesca Cesari, Elisabetta Surrenti, Rosanna Abbate, Gian Franco Gensini, Stefano Benedettelli, Alessandro Casini. Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomised dietary intervention trial. Br J Nutr. 2014 June 14; 111(11): 1992–1999
341. Norsk Helseinformatikk. FODMAP redusert diett hjelper mot irritabel tarm. http://nhi.no/forside/fodmap-redusert-diett-hjelper-mot-irritabel-tarm-41852.html
342. Halmos, Emma P. et al. A Diet Low in FODMAPs Reduces Symptoms of Irritable bowel Syndrome. Gastroenterology, Volume 146, Issue 1, 67–75.e5 http://gut.bmj.com/content/64/1/93.full.pdf+html
343. Staudacher HM, Lomer MC, Anderson JL, Barrett JS, Muir JG, Irving PM, Whelan K. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012 Aug;142(8):1510–8
344. Skodje, G. Norsk tidsskrift for Ernæring. Fodmap: Oversikt og oppdatering. http://www.ntfe.no/utgaver/20-nr-3-2014/142-fodmap-oversikt-og-oppdatering
345. Norsk Helseinformatikk– Dette er FODMAP reduserte matvarer. http://nhi.no/forside/dette-er-fodmap-reduserte-matvarer-41880.html
346. Wathsala S Nanayakkara, Paula ML Skidmore, Leigh O’Brien, Tim J Wilkinson, Richard B Gearry. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date. Clin Exp Gastroenterol. 2016; 9: 131–142
347. Marina Iacovou, Victoria Tan, Jane G Muir, Peter R Gibson. The Low FODMAP Diet and Its Application in East and Southeast Asia. J Neurogastroenterol Motil. 2015 October; 21(4): 459–470
348. Eleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci, Stefano Fiorucci. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol. 2016 February 21; 22(7): 2219–2241
349. Bruno P. Chumpitazi, Julia L. Cope, Emily B. Hollister, Cynthia M. Tsai, Ann R. McMeans, Ruth A. Luna, James Versalovic, Robert J. Shulman. Randomised Clinical Trial: Gut Microbiome Biomarkers are Associated with Clinical Response to a Low FODMAP Diet in Children with Irritable Bowel Syndrome. Aliment Pharmacol Ther. Aliment Pharmacol Ther. 2015 August; 42(4): 418–427
350. Suma Magge, Anthony Lembo. Low-FODMAP Diet for Treatment of Irritable Bowel Syndrome. Gastroenterol Hepatol (N Y) 2012 November; 8(11): 739–745
351. Natalia Pedersen, Zsuzsanna Vegh, Johan Burisch, Lisbeth Jensen, Dorit Vedel Ankersen, Maria Felding, Nynne Nyboe Andersen, Pia Munkholm. Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet. World J Gastroenterol. 2014 June 7; 20(21): 6680–6684
352. Louise Maagaard, Dorit V Ankersen, Zsuzsanna Végh, Johan Burisch, Lisbeth Jensen, Natalia Pedersen, Pia Munkholm. World J Gastroenterol. 2016 April 21; 22(15): 4009–4019
353. So Ra Yoon, Jong Hwa Lee, Jae Hyang Lee, Ga Yoon Na, Kyun-Hee Lee, Yoon-Bok Lee, Gu-Hun Jung, Oh Yoen Kim. Low-FODMAP formula improves diarrhea and nutritional status in hospitalized patients receiving enteral nutrition: a randomized, multicenter, double-blind clinical trial. Nutr J. 20